The response of oestrogen receptor‐positive (ER+) breast cancers (BC) to endocrine therapy (ET) is variable. ER pathway‐regulated genes have been proposed to play a role in response to ET. In… Click to show full abstract
The response of oestrogen receptor‐positive (ER+) breast cancers (BC) to endocrine therapy (ET) is variable. ER pathway‐regulated genes have been proposed to play a role in response to ET. In this study, we investigated the prognostic and predictive impacts of the expression of key ER‐regulated genes in BC.
Keywords:
regulated genes;
receptor positive;
positive breast;
oestrogen receptor;
oestrogen
Journal Title: Histopathology
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Histopathology
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!